Skip to main content
Logo
European Innovation Council
  • private sector

ATXA Therapeutics Ltd

Pharmaceutical company focused on the small molecule drug NTP42 for the treatment of pulmonary arterial hypertension (PAH).

ATXA Therapeutics Ltd logo

Overview

Description

Pharmaceutical company focused on the small molecule drug NTP42 for the treatment of pulmonary arterial hypertension (PAH).

Website
Country
  • Ireland
Sector
  • Health Biotechnology